Cargando…
Phenotypic and Expressional Heterogeneity in the Invasive Glioma Cells()()
BACKGROUND: Tumor cell invasion is a hallmark of glioblastoma (GBM) and a major contributing factor for treatment failure, tumor recurrence, and the poor prognosis of GBM. Despite this, our understanding of the molecular machinery that drives invasion is limited. METHODS: Time-lapse imaging of patie...
Autores principales: | Fayzullin, Artem, Sandberg, Cecilie J., Spreadbury, Matthew, Saberniak, Birthe Mikkelsen, Grieg, Zanina, Skaga, Erlend, Langmoen, Iver A., Vik-Mo, Einar O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172486/ https://www.ncbi.nlm.nih.gov/pubmed/30292065 http://dx.doi.org/10.1016/j.tranon.2018.09.014 |
Ejemplares similares
-
The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy
por: Skaga, Erlend, et al.
Publicado: (2019) -
A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
por: Kierulf-Vieira, Kirsten Strømme, et al.
Publicado: (2020) -
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
por: Stangeland, Biljana, et al.
Publicado: (2015) -
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
por: Skaga, Erlend, et al.
Publicado: (2019) -
TBIO-18. ESTABLISHING A PIPELINE FOR INDIVIDUALIZED TREATMENT OPTIONS FOR PEDIATRIC BRAIN CANCER
por: Djirackor, Luna, et al.
Publicado: (2020)